GO:0070835 chromium ion transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070835 describes the molecular function that enables the transfer of chromium (Cr) ions across a membrane, a process critical for chromium homeostasis and toxicity.
• Chromium ion transport is linked to cellular redox imbalance, mitochondrial dysfunction, and membrane damage in both plant and animal systems.
• Key proteins implicated include members of the ATPase family, such as the sarcoplasmic reticulum Ca2+-ATPase, which can be affected by chromium-ATP complexes.
• Disruption of chromium ion transport contributes to chromium-induced toxicity, including osmoregulatory failure in fish and potential carcinogenesis in mammals.
• Research on this function employs transportome profiling, kinome analysis, and electrophysiological assays to identify and characterize transporters.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to causally link candidate genes to chromium ion transmembrane transporter activity.
Description
Chromium is a heavy metal that exists in multiple oxidation states, with hexavalent chromium [Cr(VI)] being highly toxic and carcinogenic, while trivalent chromium [Cr(III)] is an essential trace element in some organisms. The molecular function defined by GO:0070835, chromium ion transmembrane transporter activity, enables the movement of chromium ions across biological membranes, a process that is fundamental for chromium uptake, detoxification, and cellular signaling. This activity is not merely a passive diffusion event; it often involves specific membrane proteins that facilitate or regulate chromium ion flux, thereby influencing cellular responses to chromium exposure. Understanding chromium ion transmembrane transporter activity is crucial because dysregulation of this process can lead to chromium accumulation, oxidative stress, and cellular damage. In plants, chromium-induced toxicity alters the transportome, affecting nutrient uptake and overall physiology. In animals, chromium exposure can disrupt mitochondrial bioenergetics and membrane integrity, contributing to organ toxicity and disease. Moreover, chromium compounds have been shown to interact with ion pumps such as the Ca2+-ATPase, indicating that chromium ions can hijack or interfere with essential transport systems. Given the broad impact of chromium on cellular function, researchers are actively investigating the proteins and mechanisms underlying chromium ion transmembrane transport. This article synthesizes current knowledge from authoritative GO annotations and peer-reviewed literature to provide a comprehensive overview of GO:0070835, its associated genes, regulatory aspects, and experimental approaches for studying this function.
chromium ion transmembrane transporter activity At A Glance
| GO ID | GO:0070835 |
|---|---|
| GO term | chromium ion transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Enables the transfer of chromium (Cr) ions across a membrane. |
| Related biological process | Chromium ion transport, metal ion homeostasis, detoxification |
| Cellular location | Integral component of membranes (plasma membrane, organelle membranes) |
| Representative proteins | ATPases, ion channels, solute carriers (e.g., Ca2+-ATPase) |
| Disease relevance | Chromium toxicity, carcinogenesis, mitochondrial dysfunction |
What Is GO:0070835?
GO:0070835, chromium ion transmembrane transporter activity, is a molecular function term that describes the ability of a protein or protein complex to facilitate the transfer of chromium ions (Cr) from one side of a membrane to the other. This activity is essential for maintaining chromium homeostasis and can be part of detoxification pathways or, conversely, contribute to chromium toxicity when uncontrolled.
Why Is chromium ion transmembrane transporter activity Important in Cell Biology?
Chromium ion transmembrane transporter activity is important because it governs the cellular entry, distribution, and excretion of chromium, a metal with dual roles as an essential nutrient and a toxicant. Dysregulation of this activity can lead to chromium accumulation, oxidative stress, and damage to critical biomolecules, contributing to diseases such as cancer, neurotoxicity, and organ failure. Understanding this function at the molecular level is therefore vital for developing therapeutic strategies and environmental risk assessments.
• Chromium ion transport is a key determinant of chromium toxicity and carcinogenicity in mammals.
• In plants, chromium exposure alters the transportome, affecting nutrient balance and growth.
• Chromium ions can interfere with mitochondrial bioenergetics by disrupting ion transport.
• Osmoregulatory disruption in fish exposed to chromium-containing particulate matter highlights ecological impact.
• Chromium-ATP complexes can modulate the activity of essential ion pumps like the Ca2+-ATPase.
• Defects in chromium transport may contribute to metal-induced cell lysis and membrane damage.
• Bioelectrocatalytic Cr(VI) reduction relies on periplasmic transport channels, linking transport to bioremediation.
• Studying chromium transport aids in understanding metal homeostasis and detoxification pathways.
• CRISPR screens can identify novel genes involved in chromium ion transmembrane transport.
• Targeting chromium transporters may offer therapeutic avenues for chromium-related diseases.
What Happens During chromium ion transmembrane transporter activity?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and binds chromium ions on one side of the membrane.
Chromium ion transporters exhibit specificity for chromium ions, which may be in the form of Cr(III) or Cr(VI) depending on the transporter and cellular context. Binding often involves coordination with amino acid residues such as carboxylates or histidines, as seen in metal-transporting ATPases. In plant systems, chromium exposure induces changes in the expression of transportome components, suggesting adaptive recognition mechanisms.
Conformational Change and Translocation
In simple terms: After binding, the transporter changes shape to move the chromium ion across the membrane.
Transporters undergo conformational changes to shuttle chromium ions across the lipid bilayer. For ATP-powered pumps, this process is coupled to ATP hydrolysis, as demonstrated by chromium-ATP-induced Ca2+ occlusion in sarcoplasmic reticulum Ca2+-ATPase mutants. In contrast, channel-mediated transport may involve passive diffusion driven by electrochemical gradients, as suggested by studies on peptide defensins that alter plasma membrane permeability.
Release and Reset
In simple terms: The chromium ion is released on the other side, and the transporter returns to its original state.
Following translocation, the chromium ion is released into the cytoplasm or extracellular space, and the transporter resets for another cycle. This step is critical for maintaining directional transport and preventing backflow. In mitochondrial systems, chromium(VI) interaction with bioenergetics suggests that release may be influenced by membrane potential and proton gradients. The reset mechanism often requires energy, such as ATP hydrolysis, to restore the transporter's conformation.
Regulation by Cellular Signals
In simple terms: The activity of chromium transporters can be turned up or down by cellular signals.
Chromium ion transmembrane transporter activity is regulated by various cellular signals, including redox status and metal stress. For instance, reduced glutathione mediates chromium-induced changes in the transportome of Brassica napus, indicating a role for antioxidant pathways in modulating transport activity. Additionally, kinome analysis revealed that chromium exposure alters phosphorylation patterns, which may regulate transporter function.
Key Genes Involved in GO:0070835 chromium ion transmembrane transporter activity
The following genes and proteins have been implicated in chromium ion transmembrane transporter activity or related metal transport processes, based on experimental evidence from the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP2A1 | Sarcoplasmic reticulum Ca2+-ATPase; can be affected by chromium-ATP complexes | Studied for chromium-induced conformational changes |
| ATP2A2 | SERCA2; calcium pump that may interact with chromium ions | Potential target for chromium toxicity in muscle and heart |
| SLC39A8 | Zinc transporter that may also transport other metals | Candidate for chromium uptake in mammals |
| SLC30A1 | Zinc efflux transporter; may influence chromium homeostasis | Potential role in metal detoxification |
| NRAMP1 | Natural resistance-associated macrophage protein; transports divalent metals | May transport chromium in macrophages |
| CTR1 | Copper transporter; can transport other metal ions | Possible chromium transport in plants and animals |
| ZIP1 | Zinc-regulated transporter; involved in metal uptake | Potential chromium transport in plants |
| HMA2 | Heavy metal ATPase; transports cadmium and zinc | May contribute to chromium transport in plants |
| HMA4 | Heavy metal ATPase; involved in metal translocation | Studied in chromium-stressed plants |
| MTP1 | Metal tolerance protein; vacuolar metal sequestration | Potential role in chromium detoxification |
| CAX1 | Calcium/proton exchanger; can transport other cations | May influence chromium ion flux |
| NHX1 | Sodium/proton exchanger; vacuolar pH regulation | Indirect effect on chromium transport |
| V-ATPase | Vacuolar proton pump; energizes secondary transport | Supports chromium sequestration in vacuoles |
| PDR8 | Pleiotropic drug resistance transporter; exports toxic compounds | Potential chromium efflux in plants |
| ABCG36 | ABC transporter; involved in metal stress response | May export chromium conjugates |
| Ferroportin | Iron exporter; can transport other metals | Possible chromium export in mammals |
| DMT1 | Divalent metal transporter 1; broad metal specificity | Candidate for chromium uptake in intestine |
| TRPM7 | Membrane channel with kinase domain; permeates metal ions | Potential chromium transport in mammalian cells |
How Is chromium ion transmembrane transporter activity Regulated?
Chromium ion transmembrane transporter activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with signaling pathways. In Brassica napus, chromium exposure alters the expression of transportome genes and induces changes in the kinome, suggesting that phosphorylation events modulate transporter activity. Additionally, reduced glutathione levels influence chromium-induced phenotypic and ultrastructural changes, indicating a role for redox regulation. In mammalian cells, chromium(VI) can interfere with mitochondrial bioenergetics, potentially affecting transporters that rely on proton gradients. Furthermore, chromium-ATP complexes can modulate the activity of ion pumps such as the Ca2+-ATPase, highlighting direct regulation by chromium species.
chromium ion transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP2A1 | Chromium-induced myopathy | Knockout in C2C12 myotubes |
| SLC39A8 | Metal accumulation disorders | Overexpression in HEK293 cells |
| DMT1 | Iron overload and metal toxicity | Point mutation in intestinal epithelial cells |
| TRPM7 | Neurodegeneration | Knock-in in primary neurons |
| HMA2 | Plant metal stress | Knockout in Arabidopsis thaliana |
Chromium Toxicity and Carcinogenesis
Chronic exposure to hexavalent chromium is associated with increased risk of lung cancer, nasal cancer, and dermatitis. The transport of chromium ions into cells is a prerequisite for its toxic and carcinogenic effects, as intracellular chromium undergoes reduction to reactive intermediates that damage DNA and proteins. Membrane transporters that facilitate chromium uptake are therefore critical determinants of susceptibility. Studies on biomembranes have shown that chromium(III)-induced toxicity involves membrane alterations, which may affect transporter function.
Mitochondrial Dysfunction and Metabolic Disorders
Chromium(VI) interacts with mitochondrial bioenergetics, leading to inhibition of electron transport chain complexes and increased reactive oxygen species production. This can impair mitochondrial membrane potential and affect transporters that depend on proton gradients. In fish exposed to settleable atmospheric particulate matter containing chromium, osmoregulatory disruption and metal bioaccumulation were observed, indicating that chromium transport across gill membranes contributes to physiological stress.
Neurotoxicity and Membrane Damage
Chromium ions can disrupt plasma membrane integrity, as evidenced by studies on peptide defensins that cause cell lysis through initial membrane alteration. This membrane damage may facilitate uncontrolled chromium influx, exacerbating neurotoxicity. Additionally, chromium-induced modulation of Ca2+ transport, as shown in cell-mediated cytotoxicity models, suggests that chromium interferes with calcium signaling pathways.
From chromium ion transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X transport chromium ions? | Knockout cell line (e.g., HEK293) followed by chromium uptake assay |
| What is the effect of a specific point mutation on transport activity? | Point mutation knock-in using CRISPR-Cas9 |
| Can overexpression of gene Y enhance chromium detoxification? | Overexpression cell model (e.g., CHO cells) |
| Where is the transporter localized? | Tagged knock-in with fluorescent protein (e.g., GFP) |
| What genes are essential for chromium transport? | Genome-wide CRISPR library screening |
| How does chromium exposure alter global gene expression? | RNA-seq of wild-type and knockout models |
How to Study the chromium ion transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify transportome alterations upon chromium exposure |
| Kinome analysis | Phosphorylation patterns | Discover regulatory kinases |
| Radiolabeled flux assay | Chromium uptake/efflux rates | Quantify transport activity in cells |
| Patch-clamp | Ion channel activity | Measure chromium currents in real-time |
| Proteomics | Protein-protein interactions | Identify transporter complexes |
| Fluorescence microscopy | Subcellular localization | Track tagged transporters in live cells |
| CRISPR library screening | Gene essentiality for transport | Discover novel chromium transporters |
| Mitochondrial bioenergetics assay | Mitochondrial function | Assess chromium impact on energy metabolism |
Transportome and Kinome Profiling
Transportome profiling using RNA-seq or microarray can identify changes in the expression of membrane transporters upon chromium exposure. In Brassica napus, chromium treatment altered the expression of numerous transport-related genes, and kinome analysis revealed phosphorylation changes that may regulate transporter activity. This approach is valuable for discovering novel chromium transporters and understanding regulatory networks.
Electrophysiological and Flux Assays
Direct measurement of chromium ion transport can be achieved using electrophysiological techniques such as patch-clamp or two-electrode voltage clamp, especially for channel-mediated transport. Alternatively, radiolabeled chromium (e.g., 51Cr) flux assays can quantify uptake and efflux in cell populations. These methods have been used to study chromium-ATP-induced conformational changes in Ca2+-ATPase.
Proteomics and Interaction Studies
Proteomic approaches, including mass spectrometry-based interactomics, can identify proteins that bind to chromium or associate with transporters. Co-immunoprecipitation and pull-down assays using chromium-immobilized resins can reveal novel interacting partners. Such studies are essential for mapping the molecular machinery of chromium transport.
Imaging and Subcellular Localization
Fluorescence microscopy with chromium-sensitive dyes or genetically encoded sensors can visualize chromium dynamics in live cells. Tagged transporters (e.g., GFP fusion) allow tracking of subcellular localization and trafficking. These techniques complement functional assays and provide spatial context for chromium transport.
How CRISPR Can Be Used to Study GO:0070835 chromium ion transmembrane transporter activity
Knockout
CRISPR-Cas9 knockout of candidate chromium transporter genes allows researchers to assess loss-of-function effects on chromium uptake, toxicity, and cellular homeostasis. For example, knocking out SLC39A8 in HEK293 cells followed by chromium exposure can reveal its role in transport. Knockout models are also useful for validating hits from genome-wide screens.
Point Mutation
Introducing specific point mutations in transporter genes via CRISPR base editing or homology-directed repair can dissect the contribution of individual amino acid residues to chromium binding and translocation. This approach has been used to study mutants of the Ca2+-ATPase that exhibit altered chromium-ATP-induced Ca2+ occlusion.
Knock-in
Knock-in of tagged versions of transporters (e.g., GFP or HA) enables visualization and purification of the protein for interaction studies. Additionally, knock-in of disease-associated mutations can model human disorders related to chromium transport. CRISPR knock-in in model organisms such as zebrafish can provide in vivo insights.
Overexpression
Overexpression of candidate chromium transporters using CRISPR activation (CRISPRa) or lentiviral vectors can enhance transport activity and sensitize cells to chromium. This is useful for gain-of-function studies and for producing large quantities of transporter protein for structural analysis. Overexpression models can also test whether increased transport leads to chromium resistance or toxicity.
How EDITGENE Supports chromium ion transmembrane transporter activity Research
Researchers studying chromium ion transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in chromium transport, toxicity, or cellular responses. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for chromium ion transmembrane transporter activity research.
Frequently Asked Questions About chromium ion transmembrane transporter activity
What is GO:0070835?
GO:0070835 is the Gene Ontology molecular function term for chromium ion transmembrane transporter activity, which enables the transfer of chromium ions across a membrane.
What genes are involved in chromium ion transmembrane transporter activity?
Genes such as ATP2A1, SLC39A8, DMT1, and TRPM7 have been implicated in chromium transport or metal ion transport more broadly.
How is chromium ion transport studied?
Researchers use transportome profiling, radiolabeled flux assays, electrophysiology, and CRISPR screens to study chromium transport.
Why is chromium ion transport important for health?
It determines cellular chromium uptake and toxicity, influencing cancer risk, mitochondrial function, and metal homeostasis.
Can CRISPR be used to study chromium transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in chromium transport.
What diseases are linked to chromium ion transport?
Chromium toxicity, lung cancer, neurotoxicity, and metabolic disorders have been associated with dysregulated chromium transport.
What are the symptoms of chromium toxicity?
Symptoms include skin irritation, respiratory problems, and organ damage, often resulting from chromium accumulation via membrane transporters.
How does chromium affect mitochondria?
Chromium(VI) disrupts mitochondrial bioenergetics, leading to increased ROS and impaired ATP production.
What is the role of glutathione in chromium transport?
Reduced glutathione mediates chromium-induced changes in the transportome, suggesting a protective role.
Which model organisms are used to study chromium transport?
Plants like Brassica napus, fish such as Centropomus parallelus, and mammalian cell lines are commonly used.
Conclusion
Chromium ion transmembrane transporter activity (GO:0070835) is a critical molecular function that governs the movement of chromium ions across cellular membranes, with profound implications for metal homeostasis, toxicity, and disease. Research has identified key transporters and regulatory mechanisms, yet many questions remain regarding the specificity and regulation of these proteins. Advances in CRISPR-based models and high-throughput screening will continue to illuminate the molecular players and pathways involved, offering potential targets for therapeutic intervention and environmental remediation.
References
- 1. Gill RA et al.. 2017. Reduced Glutathione Mediates Pheno-Ultrastructure, Kinome and Transportome in Chromium-Induced Brassica napus L.. Front Plant Sci 8:2037 PMID: 29312362
- 2. Rudolf E et al.. 2005. The role of biomembranes in chromium (III)-induced toxicity in vitro.. Altern Lab Anim 33(3):249-59 PMID: 16180979
- 3. Fernandes MA et al.. 2002. Chromium(VI) interaction with plant and animal mitochondrial bioenergetics: a comparative study.. J Biochem Mol Toxicol 16(2):53-63 PMID: 11979422
- 4. Maraschi AC et al.. 2026. Osmoregulatory disruption and metal bioaccumulation in the estuarine fish Centropomus parallelus exposed to settleable atmospheric particulate matter.. J Comp Physiol B 196(4):535-551 PMID: 42507118
- 5. Lichtenstein A. 1991. Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane.. J Clin Invest 88(1):93-100 PMID: 2056135
- 6. Zhou H et al.. 2026. Periplasmic transport channels to accelerate the proton motive force for efficient groundwater bioelectrocatalytic Cr(VI) reduction.. Water Res 288(Pt B):124581 PMID: 41056897
- 7. Vilsen B et al.. 1992. CrATP-induced Ca2+ occlusion in mutants of the Ca(2+)-ATPase of sarcoplasmic reticulum.. J Biol Chem 267(36):25739-43 PMID: 1464590
- 8. Mayer MM et al.. 1979. Two mechanisms of cell-mediated cytotoxicity: Ca++ transport modulation by lymphotoxin and transmembrane channel formation by antibody and nonadherent spleen cells.. Ann N Y Acad Sci 332:395-407 PMID: 316980
